T.O. Goetze
机构：Goethe University Frankfurt, Institute of Clinical Cancer Research, University Hospital Frankfurt, Frankfurt Cancer Institute
发表论文 12 篇 · 总被引 15 次 · h-index 3
代表论文
- P1.11-01 Cobolimab with Dostarlimab and Docetaxel in Patients with Advanced Non-small Cell Lung Cancer (NSCLC): COSTAR Lung (2022 · Journal of Thoracic Oncology · 被引 8)
- LBA51 IKF-035/ABC-HCC: A phase IIIb, randomized, multicenter, open-label trial of atezolizumab plus bevacizumab versus transarterial chemoembolization (TACE) in intermediate-stage hepatocellular carcinoma (2025 · Annals of Oncology · 被引 4)
- 1016eTiP A first-in-human phase I study of LY4066434, a potent and orally bioavailable pan-KRAS inhibitor, in KRAS-mutant solid tumors (Trial in Progress) (2025 · Annals of Oncology · 被引 3)
- 647eTiP NeoTISLEGA: AIO/IKF phase Ib trial evaluating a total neoadjuvant concept with tislelizumab plus FLOT for resectable esophagogastric adenocarcinoma (2026 · Annals of Oncology)
- 225P IKF-t045/ADVANCE: A phase II single-arm, open-label study of atezolizumab and derazantinib for patients with advanced intrahepatic cholangiocarcinoma with FGFR2 fusions/rearrangements (2026 · Annals of Oncology)
- 74P Machine learning-derived serum biomarker signatures for treatment selection and monitoring in advanced colorectal cancer patients receiving trifluridine/tipiracil plus ramucirumab: Translational analysis of the RAMTAS trial (AIO-KRK-0316/IKF643) (2026 · Annals of Oncology)